Company News »

SurModics to Present at RBC Capital Markets Global Healthcare Conference

Business Wire
Share on StockTwits
Published on

SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that Gary Maharaj, president and chief executive officer, will make a presentation to the investment community at the RBC Capital Markets Global Healthcare Conference on Tuesday, February 24, 2015, at 10 a.m. ET (9 a.m. CT) in New York City.

A live audio webcast of the presentation will be available by going to the investor relations portion of the Company’s website at www.surmodics.com and clicking on the webcast icon. An audio replay will be available beginning at 10:30 a.m. CT on Tuesday, February 24, and is accessible for 90 days.

About SurModics, Inc.
SurModics partners with the world’s leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. Our mission is to be a trusted partner to our customers by providing the most advanced surface modification technologies and in vitro diagnostic chemical components that help enhance the well-being of patients. The company’s core offerings include surface modification coating technologies that impart lubricity, prohealing and biocompatibility characteristics and components for in vitro diagnostic test kits and microarrays. SurModics’ strategy is to build on the product and technical leadership within these fields, and expand the core offerings to generate opportunities for longer term sustained growth. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit www.surmodics.com. The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.

Share on StockTwits